NextCure, Inc. Files 8-K Report
Ticker: NXTC · Form: 8-K · Filed: Apr 10, 2025 · CIK: 1661059
| Field | Detail |
|---|---|
| Company | Nextcure, Inc. (NXTC) |
| Form Type | 8-K |
| Filed Date | Apr 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, regulatory
TL;DR
NextCure filed an 8-K, mostly procedural stuff, no major news yet.
AI Summary
On April 10, 2025, NextCure, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the filing of Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates NextCure, Inc. is providing updates to the SEC, which could contain important information for investors regarding financial status or regulatory compliance.
Risk Assessment
Risk Level: low — The provided excerpt is a standard 8-K filing notification and does not contain specific material events or financial data that would indicate a change in risk.
Key Players & Entities
- NextCure, Inc. (company) — Registrant
- April 10, 2025 (date) — Date of earliest event reported
- Beltsville, Maryland (location) — Principal executive offices location
FAQ
What is the primary purpose of this 8-K filing by NextCure, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and the filing of Financial Statements and Exhibits.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is April 10, 2025.
Where are NextCure, Inc.'s principal executive offices located?
NextCure, Inc.'s principal executive offices are located at 9000 Virginia Manor Road, Suite 200, Beltsville, Maryland 20705.
What is the Commission File Number for NextCure, Inc.?
The Commission File Number for NextCure, Inc. is 001-38905.
What is the IRS Employer Identification Number for NextCure, Inc.?
The IRS Employer Identification Number for NextCure, Inc. is 47-5231247.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 10, 2025 regarding NextCure, Inc. (NXTC).